You have a product that could be a medical device or a wellness product, depending on the claims you make. Your team is small. Your budget is limited. Your investors want revenue. The MDR path takes 18 to 36 months and costs six figures minimum. Launching as a wellness product takes weeks and costs a fraction.
The beachhead strategy — launching as a wellness product first, then transitioning to a certified medical device later — is a legitimate path. Tibor has seen it work. He has also seen it fail spectacularly. The difference is execution.
Here is how to do it right.
What Is the Beachhead Strategy?
In military terms, a beachhead is the initial position you establish on hostile territory before advancing further. In MedTech startup terms, it means entering the market with a non-medical version of your product — establishing revenue, user base, and market validation — before pursuing the full MDR compliance path for medical claims.
The logic is straightforward: 1. Launch with general wellness claims (no MDR required) 2. Generate revenue and collect real-world usage data 3. Use that revenue and data to fund and inform the MDR certification process 4. Transition to a certified medical device with medical claims
This is not a shortcut around the MDR. It is a sequencing strategy. The medical device certification still happens — it just happens after you have established a market presence rather than before.
When Does This Strategy Make Sense?
The beachhead approach works when four conditions are met:
1. Your product has genuine non-medical value. If the only reason someone would buy your product is for a medical purpose, launching as wellness is a fiction. The product must have real standalone value as a wellness, fitness, or general health product. A wearable that tracks activity, sleep, and general health metrics has standalone wellness value. A surgical instrument does not.
2. The medical claims are an upgrade, not the core. If your entire business case depends on medical claims — if insurance reimbursement or clinical adoption is your primary revenue model — then the wellness phase does not serve your business. You need the medical claims to make money.
3. Your wellness claims are genuine. You must actually operate as a wellness company during the wellness phase. Your marketing must reflect wellness positioning. Your product must not make medical claims. This is not a fig leaf — competent authorities can and do investigate companies that claim to be wellness while acting like medical device manufacturers.
4. You can fund the MDR transition from wellness revenue. The transition from wellness to medical device requires full MDR compliance — QMS, technical documentation, clinical evidence, Notified Body audit. If your wellness revenue cannot fund this transition, or if you cannot raise additional capital for it, the beachhead strategy becomes a permanent wellness positioning, not a transition strategy.
How Did One Startup Execute This Successfully?
Tibor worked with a Graz-based company that initially planned to enter the market as a medical device. After analyzing their product, he identified that a slight modification to their intended purpose — not the technology, just the regulatory positioning — would allow them to launch as a wellness product first.
The company launched with wellness claims. They generated revenue. They collected usage data. They built a user base. And they used that foundation to fund their MDR certification process — which they entered with real-world data that strengthened their clinical evaluation and with revenue that funded their regulatory investment.
The key: the wellness positioning was genuine. They did not make medical claims during the wellness phase. They did not market to patients. They did not reference specific diseases. When they later transitioned to medical claims, they went through the complete MDR path with no shortcuts.
What Are the Traps?
Trap 1: Making medical claims during the wellness phase.
This is the most common failure. The startup officially positions as wellness but cannot resist the temptation to make medical-sounding claims in marketing. "Our device helps you detect early signs of cardiac problems" — that is a medical claim. "Validated by cardiologists for arrhythmia detection" — medical claim. Even "clinically proven" can be problematic if it implies a medical diagnostic capability.
If you make medical claims without MDR compliance, you are placing an unregulated medical device on the market. This violates Article 5 of the MDR and exposes you to enforcement, recall, and potential liability.
Trap 2: Designing without considering future MDR requirements.
If you design your wellness product with zero regard for MDR requirements, transitioning later becomes expensive. Medical device design requires design controls, risk management documentation, traceability of requirements, and validation of every design change. Retrofitting these onto a product that was designed without them is often more costly than starting with them.
The smart approach: during the wellness phase, implement the basic infrastructure that the MDR will later require — even if you are not yet obligated to do so. Use design controls. Document your design decisions. Implement basic risk management. Keep traceability records. These practices do not slow you down significantly during the wellness phase, and they save enormous time and money during the transition.
Trap 3: Assuming the transition is easy.
The transition from wellness to medical device is not a paperwork exercise. It requires: - Establishing a quality management system compliant with EN ISO 13485 - Compiling technical documentation per Annex II and III - Conducting a full clinical evaluation per Article 61 and Annex XIV - Engaging a Notified Body and undergoing Stage 1 and Stage 2 audits - Addressing any non-conformities identified during the audit - Obtaining your CE mark
This process takes 12 to 24 months at minimum, even if you have prepared well during the wellness phase. It is a full regulatory project with full regulatory costs.
Trap 4: Regulatory creep.
Over time, your sales team starts making bolder claims. Your marketing gets closer and closer to medical territory. Your customer success team answers questions about medical use cases. Slowly, without a deliberate decision, your wellness product starts functioning as an unregulated medical device in practice.
This is regulatory creep, and it is dangerous. Establish clear boundaries during the wellness phase — what claims can be made, what questions cannot be answered with medical guidance, what marketing language is off-limits. Document these boundaries. Train your team. Audit compliance regularly.
What Should You Build During the Wellness Phase?
If you plan to transition to a medical device, use the wellness phase to lay the groundwork:
Design documentation. Keep records of your design decisions, design inputs, design outputs, and verification/validation activities. You will need these for your technical documentation later.
Risk management. Start a risk management file. Identify hazards, estimate risks, and document mitigation measures. Even if you are not required to have a formal risk management process under EN ISO 14971 during the wellness phase, having one makes the transition dramatically smoother.
Usability data. Collect user feedback systematically. Document usability issues and how you addressed them. This feeds directly into your usability engineering file for MDR.
Real-world performance data. Track how your product performs in actual use. This data can support your clinical evaluation when you transition to medical device status.
Regulatory intelligence. Monitor the MDR, MDCG guidance, and relevant harmonized standards. The regulatory environment evolves — what is required when you start the transition may differ from what was required when you launched as wellness.
Notified Body relationship. Start identifying and engaging with Notified Bodies early. Wait times are long. If you can initiate contact during the wellness phase, you shorten your transition timeline.
How Do You Handle Investors?
Investors often push for medical claims because they increase the addressable market and justify higher valuations. The beachhead strategy needs to be explained clearly to investors:
"We are entering the market as a wellness product to generate revenue and collect real-world data. We will pursue MDR certification as our next phase, which will allow us to make medical claims and access clinical and reimbursement channels. The wellness revenue funds the regulatory investment. The real-world data strengthens our clinical evaluation. This is a de-risked approach to a regulated market."
This framing is honest, logical, and addresses the investor's core concern (market size) while explaining the sequencing (wellness first, medical second).
The Bottom Line on the Beachhead Strategy
The beachhead approach is not right for every startup. It works when your product has genuine non-medical value, when the medical claims are an enhancement rather than the core proposition, and when you have the discipline to maintain clean wellness positioning during the first phase.
It does not work when your product's only value is medical, when your market requires medical claims from day one, or when you lack the discipline to avoid medical claims during the wellness phase.
Done right, it gives you revenue, data, and market presence before you face the full weight of MDR compliance. Done wrong, it gives you an unregulated medical device on the market, a competent authority investigation, and a reputation problem you cannot recover from.
Next: MDR Annex I: General Safety and Performance Requirements Explained for Startups.